These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 3596357)

  • 1. Treatment of deep venous thrombosis with a very low molecular weight heparin fragment (CY 222).
    Janvier G; Winnock S; Dugrais G; Vallet A; Dardel E; Serisé JM; Calen S; Vergnes C; Toulemonde F
    Haemostasis; 1987; 17(1-2):49-58. PubMed ID: 3596357
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A new treatment of deep venous thrombosis: low molecular weight heparin fractions. Randomized study].
    Faivre R; Neuhart Y; Kieffer Y; Apfel F; Magnin D; Didier D; Toulemonde F; Bassand JP; Maurat JP
    Presse Med; 1988 Feb; 17(5):197-200. PubMed ID: 2965375
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [CY 222, a very low molecular weight heparin, in the curative treatment of deep venous thrombosis. Apropos of 95 cases. Clinical and phlebographic results].
    Janvier G; Dugrais G; Winnock S; Vergnes C; Boisseau M; Broussin J; Serise JM; Boissieras P; Videau J; Toulemonde F
    J Mal Vasc; 1987; 12 Suppl B():141-4. PubMed ID: 2834487
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomised trial of subcutaneous low molecular weight heparin (CY 216) compared with intravenous unfractionated heparin in the treatment of deep vein thrombosis. A collaborative European multicentre study.
    Thromb Haemost; 1991 Mar; 65(3):251-6. PubMed ID: 1646490
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An open trial of enoxaparin in the treatment of deep vein thrombosis of the leg.
    Janvier G; Freyburger G; Winnock S; Dugrais G; Boisseau M; Boissiéras P
    Haemostasis; 1991; 21(3):161-8. PubMed ID: 1663476
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Once-daily subcutaneous dalteparin, a low molecular weight heparin, for the initial treatment of acute deep vein thrombosis.
    Fiessinger JN; Lopez-Fernandez M; Gatterer E; Granqvist S; Kher A; Olsson CG; Söderberg K
    Thromb Haemost; 1996 Aug; 76(2):195-9. PubMed ID: 8865530
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of heparin and streptokinase in the treatment of venous thrombosis.
    Porter JM; Seaman AJ; Common HH; Rösch J; Eidemiller LR; Calhoun AD
    Am Surg; 1975 Sep; 41(9):511-19. PubMed ID: 1101755
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Late sequelae of deep venous thrombosis: a 13-year follow-up of 223 patients].
    Eichlisberger R; Frauchiger B; Widmer MT; Widmer LK; Jäger K
    Vasa; 1994; 23(3):234-43. PubMed ID: 7975869
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The antithrombotic effect of heparin in deep venous thrombosis: relation to four heparin assays.
    Holm HA; Abildgaard U; Kalvenes S; Anderssen N; Anker E; Arnesen KE; Blikom D; Drivenes A
    Acta Med Scand; 1984; 216(3):287-93. PubMed ID: 6496186
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention of deep-vein thrombosis and pulmonary embolism after total hip replacement. Comparison of low-molecular-weight heparin and unfractionated heparin.
    Eriksson BI; Kälebo P; Anthymyr BA; Wadenvik H; Tengborn L; Risberg B
    J Bone Joint Surg Am; 1991 Apr; 73(4):484-93. PubMed ID: 2013587
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of a low molecular weight heparin administered intravenously or subcutaneously in comparison with intravenous unfractionated heparin in the treatment of deep venous thrombosis. Certoparin-Study Group.
    Kirchmaier CM; Wolf H; Schäfer H; Ehlers B; Breddin HK
    Int Angiol; 1998 Sep; 17(3):135-45. PubMed ID: 9821025
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subcutaneous low molecular weight heparin versus subcutaneous unfractionated heparin in the treatment of deep vein thrombosis: a Polish multicenter trial.
    Lopaciuk S; Meissner AJ; Filipecki S; Zawilska K; Sowier J; Ciesielski L; Bielawiec M; Glowinski S; Czestochowska E
    Thromb Haemost; 1992 Jul; 68(1):14-8. PubMed ID: 1325076
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two daily subcutaneous injections of fragmin as compared with intravenous standard heparin in the treatment of deep venous thrombosis (DVT).
    Bratt G; Aberg W; Johansson M; Törnebohm E; Granqvist S; Lockner D
    Thromb Haemost; 1990 Dec; 64(4):506-10. PubMed ID: 1964751
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Subcutaneous heparin treatment of deep venous thrombosis: a comparison of unfractionated and low molecular weight heparin.
    Holm HA; Ly B; Handeland GF; Abildgaard U; Arnesen KE; Gottschalk P; Høeg V; Aandahl M; Haugen K; Laerum F
    Haemostasis; 1986; 16 Suppl 2():30-7. PubMed ID: 3527886
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Streptokinase therapy in the routine management of deep venous thrombosis in the lower extremities. A retrospective study of phlebographic results and therapeutic complications.
    Ott P; Eldrup E; Oxholm P; Vestergård A; Knudsen JB
    Acta Med Scand; 1986; 219(3):295-300. PubMed ID: 3706003
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison between low molecular weight heparin (KABI 2165) and standard heparin in the intravenous treatment of deep venous thrombosis.
    Bratt G; Törnebohm E; Granqvist S; Aberg W; Lockner D
    Thromb Haemost; 1985 Dec; 54(4):813-7. PubMed ID: 3911482
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heparin treatment of deep venous thrombosis in 280 patients: symptoms related to dosage.
    Holm HA; Finnanger B; Hartmann A; Laerum F; Løhren O; Ruud TE; Stray N; Wolland T
    Acta Med Scand; 1984; 215(1):47-53. PubMed ID: 6695563
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Treatment of deep venous thromboses with heparin. Therapeutic management and biological monitoring].
    Conard J; Horellou MH; Samama M
    Ann Med Interne (Paris); 1986; 137(6):493-6. PubMed ID: 3813285
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dosage, anticoagulant, and antithrombotic effects of heparin and low-molecular-weight heparin in the treatment of deep vein thrombosis.
    Harenberg J; Stehle G; Blauth M; Huck K; Mall K; Heene DL
    Semin Thromb Hemost; 1997; 23(1):83-90. PubMed ID: 9156415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Efficacy of a very low molecular weight heparin fragment (CY 222) compared to standard heparin in patients with deep venous thrombosis. A randomized study].
    Faivre R; Neuhart E; Kieffer Y; Bassand JP; Maurat JP
    J Mal Vasc; 1987; 12 Suppl B():145-6. PubMed ID: 2834488
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.